# Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion

> **NCT02615379** · NA · WITHDRAWN · sponsor: **Neogenix, LLC dba Ogenix**

## Conditions studied

- Instrumented Spinal Fusion

## Interventions

- **DEVICE:** EPIFLO

## Key facts

- **NCT ID:** NCT02615379
- **Lead sponsor:** Neogenix, LLC dba Ogenix
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-07-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2019-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Administrative reasons
- **Last updated:** 2017-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02615379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02615379, "Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02615379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*